(Q40754163)

23 September 2017

title

The efficacy of itraconazole against systemic fungal infections in neutropenic patients: A randomised comparative study with amphotericin B (English)

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

8 December 2022

author name string

van't Wout JW

1

1 reference

23 September 2017

J. W. van't Wout

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848268

8 December 2022

I. Novakova

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848268

8 December 2022

C. A. Verhagen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848268

8 December 2022

W. E. Fibbe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848268

8 December 2022

B. E. de Pauw

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848268

8 December 2022

J. W. van der Meer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848268

8 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1848268

8 December 2022

publication date

1 January 1991

1 reference

full work available at URL

23 September 2017

https://api.elsevier.com/content/article/PII:016344539190954Q?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

https://api.elsevier.com/content/article/PII:016344539190954Q?httpAccept=text/plain

8 December 2022

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

8 December 2022

1 reference

23 September 2017

volume

22

1 reference

23 September 2017

issue

1

1 reference

23 September 2017

page(s)

45-52

1 reference

Treatment of invasive aspergillosis with itraconazole

23 September 2017

cites work

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/0002-9343(89)90475-0

Fungal infections in the compromised host

1

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

Strategies in the treatment of systemic fungal infections

8 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

Empiric amphotericin B therapy in patients with acute leukemia

8 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

8 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy

8 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

In vitro studies with R 51,211 (itraconazole)

8 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

Azole antifungal agents: emphasis on new triazoles

8 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

Itraconazole, a new triazole that is orally active in aspergillosis

8 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

Therapeutic efficacy of itraconazole in systemic candidosis in guinea pigs.

8 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

Azole antifungal drugs: old and new.

8 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

Initial experience in therapy for progressive mycoses with itraconazole, the first clinically studied triazole

8 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

Experience with itraconazole in cryptococcosis and aspergillosis

8 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

Treatment of invasive aspergillosis with itraconazole in a patient with chronic granulomatous disease

8 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study

8 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

Diagnosis of pulmonary infection caused by Aspergillus: usefulness of respiratory cultures.

8 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis

8 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients

8 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

How to establish equivalence between treatments: a one-sided clinical trial in paediatric oncology

8 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)90954-Q

8 December 2022

Identifiers

1 reference

23 September 2017

1 reference